Trader consensus on Polymarket reflects an 86.5% implied probability that Anthropic avoids acquisition before 2027, driven by its aggressive expansion as an acquirer rather than a target. Just yesterday, April 3, 2026, Anthropic closed a $400 million all-stock deal for stealth biotech startup Coefficient Bio, following earlier buys like Vercept in February and Bun in December 2025, bolstering Claude's capabilities in drug discovery and computer use. This comes after a blockbuster $30 billion Series G funding round in February at a $380 billion post-money valuation—among the largest ever—fueling IPO speculation for late 2026 and underscoring financial independence backed by Amazon and Google partnerships. With no credible merger rumors and sky-high valuations deterring buyers, traders see minimal catalysts for a sale amid booming Claude revenue from coding tasks.
Résumé expérimental généré par IA à partir des données Polymarket · Mis à jourOui
NOUVEAU
NOUVEAU
31 déc. 2026
Oui
NOUVEAU
NOUVEAU
31 déc. 2026
This market will resolve to “Yes” if credible reporting confirms that any entity enters into an agreement to acquire Anthropic by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.Trader consensus on Polymarket reflects an 86.5% implied probability that Anthropic avoids acquisition before 2027, driven by its aggressive expansion as an acquirer rather than a target. Just yesterday, April 3, 2026, Anthropic closed a $400 million all-stock deal for stealth biotech startup Coefficient Bio, following earlier buys like Vercept in February and Bun in December 2025, bolstering Claude's capabilities in drug discovery and computer use. This comes after a blockbuster $30 billion Series G funding round in February at a $380 billion post-money valuation—among the largest ever—fueling IPO speculation for late 2026 and underscoring financial independence backed by Amazon and Google partnerships. With no credible merger rumors and sky-high valuations deterring buyers, traders see minimal catalysts for a sale amid booming Claude revenue from coding tasks.
This market will resolve to “Yes” if credible reporting confirms that any entity enters into an agreement to acquire Anthropic by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
Marché ouvert : Nov 12, 2025, 5:14 PM ET
Volume
$9,552Date de fin
31 déc. 2026Marché ouvert
Nov 12, 2025, 5:14 PM ETResolver
0x65070BE91...This market will resolve to “Yes” if credible reporting confirms that any entity enters into an agreement to acquire Anthropic by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.Trader consensus on Polymarket reflects an 86.5% implied probability that Anthropic avoids acquisition before 2027, driven by its aggressive expansion as an acquirer rather than a target. Just yesterday, April 3, 2026, Anthropic closed a $400 million all-stock deal for stealth biotech startup Coefficient Bio, following earlier buys like Vercept in February and Bun in December 2025, bolstering Claude's capabilities in drug discovery and computer use. This comes after a blockbuster $30 billion Series G funding round in February at a $380 billion post-money valuation—among the largest ever—fueling IPO speculation for late 2026 and underscoring financial independence backed by Amazon and Google partnerships. With no credible merger rumors and sky-high valuations deterring buyers, traders see minimal catalysts for a sale amid booming Claude revenue from coding tasks.
This market will resolve to “Yes” if credible reporting confirms that any entity enters into an agreement to acquire Anthropic by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to “No”.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
Mergers where Anthropic is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between Anthropic and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from Anthropic and/or its leadership, however a consensus of credible reporting will also be used.
Volume
$9,552Date de fin
31 déc. 2026Marché ouvert
Nov 12, 2025, 5:14 PM ETResolver
0x65070BE91...Trader consensus on Polymarket reflects an 86.5% implied probability that Anthropic avoids acquisition before 2027, driven by its aggressive expansion as an acquirer rather than a target. Just yesterday, April 3, 2026, Anthropic closed a $400 million all-stock deal for stealth biotech startup Coefficient Bio, following earlier buys like Vercept in February and Bun in December 2025, bolstering Claude's capabilities in drug discovery and computer use. This comes after a blockbuster $30 billion Series G funding round in February at a $380 billion post-money valuation—among the largest ever—fueling IPO speculation for late 2026 and underscoring financial independence backed by Amazon and Google partnerships. With no credible merger rumors and sky-high valuations deterring buyers, traders see minimal catalysts for a sale amid booming Claude revenue from coding tasks.
Résumé expérimental généré par IA à partir des données Polymarket · Mis à jour
Méfiez-vous des liens externes.
Méfiez-vous des liens externes.
Questions fréquentes